Determinants of foamy virus envelope glycoprotein mediated resistance to superinfection

Virology

Volumn 314, Issue 1, 2003, Pages 243-252

  Berg, Angelika ^a   Pietschmann, Thomas ^a,c   Rethwilm, Axel ^b   Lindemann, Dirk ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Envelope glycoprotein; Foamy virus; Superinfection resistance

Indexed keywords

ENVELOPE PROTEIN; PROTEIN SUBUNIT; VIRUS GLYCOPROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CATTLE; CELL SURFACE; CELL TRANSPORT; CONTROLLED STUDY; EXTRACELLULAR SPACE; HORSE; HUMAN; HUMAN CELL; INFECTION RESISTANCE; MEMBRANE; MURINE LEUKEMIA VIRUS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SECRETION; RECEPTOR BINDING; SPECIES; SPUMA VIRUS; SUPERINFECTION; VIRUS ENVELOPE;

BOVINAE; EQUIDAE; FELIDAE; HUMAN SPUMARETROVIRUS; MURINAE; MURINE LEUKEMIA VIRUS; SIMIAE;

EID: 0141680221     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00401-X     Document Type: Article

References (47)

1. Baldwin D.N., Linial M.L. The roles of Pol and Env in the assembly pathway of human foamy virus. J. Virol. 72:1998;3658-3665.
2. Battini J.L., Danos O., Heard J.M. Receptor-binding domain of murine leukemia virus envelope glycoproteins. J. Virol. 69:1995;713-719.
3. Battini J.L., Danos O., Heard J.M. Definition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor. J. Virol. 72:1998;428-435.
4. Cannon P.M., Kim N., Kingsman S.M., Kingsman A.J. Murine leukemia virus-based Tat-inducible long terminal repeat replacement vectors a new system for anti- human immunodeficiency virus gene therapy . J. Virol. 70:1996;8234-8240.
5. Delwart E.L., Panganiban A.T. Role of reticuloendotheliosis virus envelope glycoprotein in superinfection interference. J. Virol. 63:1989;273-280.
6. Dinev D., Jordan B.W., Neufeld B., Lee J.D., Lindemann D., Rapp U.R., Ludwig S. Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells. EMBO Rep. 2:2001;829-834.
7. Du Bridge R.B., Tang P., Hsia H.C., Leong P.M., Miller J.H., Calos M.P. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7:1987;379-387.
8. Dzuris J.L., Zhu W., Kapkov D., Golovkina T.V., Ross S.R. Expression of mouse mammary tumor virus envelope protein does not prevent superinfection in vivo or in vitro. Virology. 263:1999;418-426.
9. Falcone, V., Schweizer, M., Neumann-Haefelin, D., 2003. Replication of primate foamy viruses in natural and experimental hosts, in: Rethwilm, A. (Ed.), Foamy Viruses, Springer-Verlag Berlin/Heidelberg/New York. Vol. 277, in press.
10. Fischer N., Heinkelein M., Lindemann D., Enssle J., Baum C., Werder E., Zentgraf H., Müller J.G., Rethwilm A. Foamy virus particle formation. J. Virol. 72:1998;1610-1615.
11. Goepfert P.A., Shaw K.L., Ritter G.D. Jr., Mulligan M.J. A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum. J. Virol. 71:1997;778-784.
12. Goepfert P.A., Wang G., Mulligan M.J. Identification of an ER retrieval signal in a retroviral glycoprotein. Cell. 82:1995;543-544.
13. Granowitz C., Colicelli J., Goff S.P. Analysis of mutations in the envelope gene of Moloney murine leukemia virus separation of infectivity from superinfection resistance . Virology. 183:1991;545-554.
14. Hansen R., Czub S., Werder E., Herold J., Gosztonyi G., Gelderblom H., Schimmer S., Mazgareanu S., ter Meulen V., Czub M. Abundant defective viral particles budding from microglia in the course of retroviral spongiform encephalopathy. J. Virol. 74:2000;1775-1780.
15. Heard J.M., Danos O. An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor. J. Virol. 65:1991;4026-4032.
16. Helps C.R., Harbour D.A. Comparison of the complete sequence of feline spumavirus with those of the primate spumaviruses reveals a shorter gag gene. J. Gen. Virol. 78:1997;2549-2564.
17. Herchenröder O., Moosmayer D., Bock M., Pietschmann T., Rethwilm A., Bienlasz P.D., McClure M.O., Weis R., Schneider J. Specific binding of recombinant foamy virus envelope protein to host cells correlates with susceptibility to infection. Virology. 255:1999;228-236.
18. Hill C.L., Bieniasz P.D., McClure M.O. Properties of human foamy virus relevant to its development as a vector for gene therapy. J. Gen. Virol. 80:1999;2003-2009.
19. Hooks J.J., Gibbs C.J. Jr. The foamy viruses. Bacteriol. Rev. 39:1975;169-185.
20. Hunter, E., 1997. Viral entry and receptors, in: Coffin, J.M., Hughes, S.H., Varmus, H.E. (Eds.), Retroviruses, Cold Spring Harbor Laboratory Press, Plainview, NY.
21. Jassal S.R., Lairmore M.D., Leigh-Brown A.J., Brighty D.W. Soluble recombinant HTLV-1 surface glycoprotein competitively inhibits syncytia formation and viral infection of cells. Virus Res. 78:2001;17-34.
22. Jassal S.R., Pohler R.G., Brighty D.W. Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin. J. Virol. 75:2001;8317-8328.
23. Lindemann D., Bock M., Schweizer M., Rethwilm A. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J. Virol. 71:1997;4815-4820.
24. Lindemann D., Heinkelein M., Rethwilm A. Foamy virus vectors host range and replication-competent retroviral vectors . Cid-Arregui A., Garcia-Carranca A. Viral Vectors Basic Science and Gene Therapy . 1999;515-522 Eaton Publishing/Bio Techniques Books, Natick.
25. Lindemann D., Pietschmann T., Picard-Maureau M., Berg A., Heinkelein M., Thurow J., Knaus P., Zentgraf H., Rethwilm A. A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J. Virol. 75:2001;5762-5771.
26. Lindemann D., Rethwilm A. Characterization of a human foamy virus 170-kilodalton Env-Bet fusion protein generated by alternative splicing. J. Virol. 72:1998;4088-4094.
27. Linial M.L. Foamy viruses are unconventional retroviruses. J. Virol. 73:1999;1747-1755.
28. Meiering C.D., Comstock K.E., Linial M.L. Multiple integrations of human foamy virus in persistently infected human erythroleukemia cells. J. Virol. 74:2000;1718-1726.
29. Mergia A., Wu M. Characterization of provirus clones of simian foamy virus type 1. J. Virol. 72:1998;817-822.
30. Moebes A., Enssle J., Bieniasz P.D., Heinkelein M., Lindemann D., Bock M., McClure M.O., Rethwilm A. Human foamy virus reverse transcription that occurs late in the viral replication cycle. J. Virol. 71:1997;7305-7311.
31. Picard-Maureau M., Jarmy G., Berg A., Rethwilm A., Lindemann D. Foamy virus envelope glycoprotein mediated entry involves a pH-dependent fusion process. J. Virol. 77:2003;4722-4730.
32. Pietschmann T., Heinkelein M., Heldmann M., Zentgraf H., Rethwilm A., Lindemann D. Foamy virus capsids require the cognate envelope protein for particle export. J. Virol. 73:1999;2613-2621.
33. Pietschmann T., Zentgraf H., Rethwilm A., Lindemann D. An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity. J. Virol. 74:2000;4474-4482.
34. Potash M.J., Volsky D.J. Viral interference in HIV-1 infected cells. Rev. Med. Virol. 8:1998;203-211.
35. Rasheed S., Nelson-Rees W.A., Toth E.M., Arnstein P., Gardner M.B. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer. 33:1974;1027-1033.
36. Renshaw R.W., Gonda M.A., Casey J.W. Structure and transcriptional status of bovine syncytial virus in cytopathic infections. Gene. 105:1991;179-184.
37. Rethwilm A., Baunach G., Netzer K.O., Maurer B., Borisch B., ter Meulen V. Infectious DNA of the human spumaretrovirus. Nucleic Acids Res. 18:1990;733-738.
38. Saib A. Non-primate foamy viruses. Rethwilm A. Foamy Viruses. Vol 277:2003;Springer-Verlag, Berlin/Heidelberg/New York.
39. Sommerfelt M.A. Retrovirus receptors. J. Gen. Virol. 80:(12):1999; 3049-3064.
40. Sommerfelt M.A., Weiss R.A. Receptor interference groups of 20 retroviruses plating on human cells. Virology. 176:1990;58-69.
41. Soneoka Y., Cannon P.M., Ramsdale E.E., Griffiths J.C., Romano G., Kingsman S.M., Kingsman A.J. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:1995;628-633.
42. Stevenson M., Meier C., Mann A.M., Chapman N., Wasiak A. Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells mechanism for persistence in AIDS . Cell. 53:1988;483-496.
43. Swanstrom, R., Wills, J.W., 1997. Synthesis, assembly, and processing of viral proteins, in: Coffin, J. M., Hughes, S. H., Varmus, H. E. (Eds.), Retroviruses Cold Spring Harbor Laboratory Press, Plainview, NY, pp. 263-334.
44. Tobaly-Tapiero J., Bittoun P., Neves M., Guillemin M.C., Lecellier C.H., Puvion-Dutilleul F., Gicquel B., Zientara S., Giron M.L., de The H., Saib A. Isolation and characterization of an equine foamy virus. J. Virol. 74:2000;4064-4073.
45. Wang G., Mulligan M.J. Comparative sequence analysis and predictions for the envelope glycoproteins of foamy viruses. J. Gen. Virol. 80:1999;245-254.
46. Wilk T., de Haas F., Wagner A., Rutten T., Fuller S., Flugel R.M., Lochelt M. The intact retroviral Env glycoprotein of human foamy virus is a trimer. J. Virol. 74:2000;2885-2887.
47. Wilk T., Geiselhart V., Frech M., Fuller S.D., Flugel R.M., Lochelt M. Specific interaction of a novel foamy virus env leader protein with the n-terminal gag domain. J. Virol. 75:2001;7995-8007.